Mosanna
5 known investors
Find your way into Mosanna
Mosanna is a pharmaceutical company developing a non-invasive nasal spray therapy for obstructive sleep apnea (OSA) that reactivates the body's natural airway reflex to keep the upper airway open during sleep. Its lead candidate, MOS-118, is a small molecule delivered before bedtime that stimulates upper airway dilator muscles to reduce apnea and hypopnea episodes.
Founders & leadership
B
BarbaraRegulatory Affairs & Quality Assurance leadership
K
KevinPharmaceutical Development leadership
P
PranavHead of Finance & Operations
B
BenExecutive / Board
Board
DW
David WhiteSleep Medicine Advisor
Investors · 5
In the news
Frequently asked questions
- What does Mosanna do?
- Mosanna is a pharmaceutical company developing a non-invasive nasal spray therapy for obstructive sleep apnea (OSA) that reactivates the body's natural airway reflex to keep the upper airway open during sleep. Its lead candidate, MOS-118, is a small molecule delivered before bedtime that stimulates upper airway dilator muscles to reduce apnea and hypopnea episodes.
- Who are Mosanna's investors?
- Mosanna's investors include Broadview Ventures, Norwest Venture Partners, Supermoon Capital, HTGF, Pivotal Life Sciences.